SEC Form 4 · accession 0001493152-18-016231
Provention Bio, Inc. · PRVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew T Drechsler
Officer — Chief Financial Officer
Period of report
Nov 13, 2018
Accepted (ET)
Nov 14, 2018 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001695357
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 13, 2018 | M | 10,000 | $2.50 | A | 16,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.50 | Nov 13, 2018 | M | 10,000 | D | — | Sep 10, 2027 | Common Stock | 10,000 | 531,720 | D |
Explanation of responses
- F1The option was granted on September 11, 2017, pursuant to the Issuer's 2017 Equity Incentive Plan. 216,688 option shares vest in four equal annual installments commencing on September 1, 2018; the remaining 325,032 option shares vest upon completion of certain performance milestones. The completion of each milestone vests 15% of the total option shares.